Great Diamond Partners’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
BWM
FFA
KFS
CIA
Great Diamond Partners's XPH Position: Q3 2026 in Review
Great Diamond Partners opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 39,493 shares worth $2.57M. The stake represents 0.43% of the portfolio and ranks #68 among its holdings.
12 funds tracked by Wall St. Rank hold XPH as of Q3 2026.
- Great Diamond Partners held 39,493 shares of State Street SPDR S&P Pharmaceuticals ETF worth $2.57M as of Q3 2026.
- State Street SPDR S&P Pharmaceuticals ETF was a new Great Diamond Partners position in Q3 2026.
- State Street SPDR S&P Pharmaceuticals ETF made up 0.43% of Great Diamond Partners's portfolio in Q3 2026, its #68 holding.
- 12 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.
Based on Great Diamond Partners's 13F filing for Q3 2026, filed 13 Oct 2026.